The CEO & President of Jaguar Animal Health (JAGX) is Buying Shares


Today, the CEO & President of Jaguar Animal Health (NASDAQ: JAGX), Lisa Conte, bought shares of JAGX for $1,665.

This recent transaction increases Lisa Conte’s holding in the company by 25% to a total of $8,850. In addition to Lisa Conte, one other JAGX executive reported Buy trades in the last month.

See today’s analyst top recommended stocks >>

Currently, Jaguar Animal Health has an average volume of 347.8K.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Jaguar Health, Inc. engages in the dvelopment of gastrointestinal products for both human prescription use and animals. Its products include Mytesi, Canalevia, Equilevia, and Neonorm. The Mytesi product IS use for relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts